Literature DB >> 6290287

A new neuroregulator: the vasoactive intestinal peptide or VIP.

G Rosselin, M Maletti, J Besson, W Rostène.   

Abstract

VIP is a neuroregulator occurring in the central and peripheral nervous system which exhibits the function of neurotransmitter in the brain, neuroendocrine substance at the pituitary level, and neuroparacrine substance in peripheral organs. The structure and the specificity of the molecule as studied by antibody and receptor, and its location in brain and peripheral organs are summarized as well as its numerous biological effects. The method used to demonstrate the involvement of VIP in a physiological regulation is described and illustrated by two examples: the effect of VIP on gut epithelium and the neuroendocrine action of VIP in inducing prolactin release from pituitary cells. The consequence of this recent progress in the knowledge of VIP release and action in human physiology and disease is indicated.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6290287     DOI： 10.1016/0303-7207(82)90092-2

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN： 0303-7207            Impact factor:   4.102


  6 in total

1.  Lateralized hippocampal effects of vasoactive intestinal peptide on learning and memory in rats in a model of depression.

Authors:  Margarita Ivanova; Stiliana Belcheva; Iren Belcheva; Negrin Negrev; Roman Tashev
Journal:  Psychopharmacology (Berl)       Date:  2011-12-08       Impact factor: 4.530

2.  Biological pathway-based genome-wide association analysis identified the vasoactive intestinal peptide (VIP) pathway important for obesity.

Authors:  Yong-Jun Liu; Yan-Fang Guo; Li-Shu Zhang; Yu-Fang Pei; Na Yu; Ping Yu; Christopher J Papasian; Hong-Wen Deng
Journal:  Obesity (Silver Spring)       Date:  2010-04-08       Impact factor: 5.002

3.  Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study.

Authors:  D W Hsu; P N Riskind; E T Hedley-Whyte
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

4.  The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein nature.

Authors:  A el Battari; J Luis; J M Martin; J Fantini; J M Muller; J Marvaldi; J Pichon
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

5.  Lack of circadian rhythm of plasma concentrations of vasoactive intestinal peptide in patients with orthotopic heart transplants.

Authors:  P Cugini; P Lucia; G Scibilia; L Di Palma; A R Cioli; A Cianetti; L Gasbarrone; R Canova; B Marino
Journal:  Br Heart J       Date:  1993-10

6.  Vasoactive intestinal polypeptide increases whole pancreatic blood flow but does not affect islet blood flow in the rat.

Authors:  L Jansson
Journal:  Acta Diabetol       Date:  1994-06       Impact factor: 4.280
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.